1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid sodium

CAS : 1315629-79-8

Ref. 3D-IO76438

Informations sur le produit

• Nom: 1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid sodium
• Synonymes: Atorvastatin cyclic (fluorophenyl) sodium, Atorvastatin FX1 IMpurity, Atorvastatin Cyclic (Fluorophenyl) Sodium, Atorvastatin epoxy pyrrolooxazin 7hydroxy analog, 1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid sodium salt, Atorvastatin Cyclic Sodium Salt (Fluorophenyl) Impurity, 1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-Methylethyl)-1a-phenyl-7a-[(phenylaMino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic Acid SodiuM, ATV-FX1 sodiuM salt

Description

Fluoxetine is a selective serotonin reuptake inhibitor that is used to treat major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa, panic disorder, premenstrual dysphoric disorder (PMDD), and social anxiety disorder. It is also used as an appetite suppressant in some countries. Fluoxetine inhibits the neuronal uptake of serotonin by blocking the presynaptic transporter protein. The most common adverse effects are nausea, diarrhea, drowsiness, dry mouth, blurred vision and sexual dysfunction.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 613.63 g/mol
• Formule: C₃₃H₃₅FN₂O₇•Na
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder